158 related articles for article (PubMed ID: 7873132)
1. Effects of clozapine on CSF homovanillic acid in spasmodic torticollis.
Thiel A; Dressler D; Reimer A; Rüther E
J Neural Transm Gen Sect; 1994; 97(3):245-51. PubMed ID: 7873132
[TBL] [Abstract][Full Text] [Related]
2. Clozapine treatment of spasmodic torticollis.
Thiel A; Dressler D; Kistel C; Rüther E
Neurology; 1994 May; 44(5):957-8. PubMed ID: 8190304
[TBL] [Abstract][Full Text] [Related]
3. The effect of olanzapine treatment on monoamine metabolite concentrations in the cerebrospinal fluid of schizophrenic patients.
Scheepers FE; Gispen-de Wied CC; Westenberg HG; Kahn RS
Neuropsychopharmacology; 2001 Oct; 25(4):468-75. PubMed ID: 11557160
[TBL] [Abstract][Full Text] [Related]
4. The dopamine-serotonin relationship in clozapine response.
Szymanski S; Lieberman J; Pollack S; Munne R; Safferman A; Kane J; Kronig M; Cooper T
Psychopharmacology (Berl); 1993; 112(1 Suppl):S85-9. PubMed ID: 7530378
[TBL] [Abstract][Full Text] [Related]
5. Extrapyramidal reactions and amine metabolites in cerebrospinal fluid during haloperidol and clozapine treatment of schizophrenic patients.
Gerlach J; Thorsen K; Fog R
Psychopharmacologia; 1975; 40(4):341-50. PubMed ID: 1096218
[TBL] [Abstract][Full Text] [Related]
6. Homovanillic acid in the cerebrospinal fluid: patterns of response after four weeks of neuroleptic treatment.
Sharma RP; Javaid JI; Janicak PG; Davis JM; Faull K
Biol Psychiatry; 1993 Aug; 34(3):128-34. PubMed ID: 8104508
[TBL] [Abstract][Full Text] [Related]
7. Homovanillic acid in human cerebrospinal fluid.--Its concentration gradient and reduced levels in patients with epilepsy.
Kobayashi K; Koide Y; Doi T; Kohsaka M; Hosokawa K; Oku Y
Acta Med Okayama; 1978 Aug; 32(4):293-300. PubMed ID: 153090
[TBL] [Abstract][Full Text] [Related]
8. Cerebrospinal fluid homovanillic acid in the DATATOP study on Parkinson's disease. Parkinson Study Group.
Arch Neurol; 1995 Mar; 52(3):237-45. PubMed ID: 7872875
[TBL] [Abstract][Full Text] [Related]
9. The effect of lumbar puncture stress on dopamine and serotonin metabolites in human cerebrospinal fluid.
Hill KK; West SA; Ekhator NN; Bruce AB; Wortman MD; Baker DG; Geracioti TD
Neurosci Lett; 1999 Nov; 276(1):25-8. PubMed ID: 10586966
[TBL] [Abstract][Full Text] [Related]
10. Cerebrospinal fluid homovanillic acid and hypokinetic side effects of neuroleptics.
Bowers MB
Psychopharmacology (Berl); 1985; 85(2):184-6. PubMed ID: 2861619
[TBL] [Abstract][Full Text] [Related]
11. HVA and 5HIAA CSF measurements and 5HTP trials in some patients with involuntary movements.
Guilleminault C; Tharp BR; Cousin D
J Neurol Sci; 1973 Apr; 18(4):435-41. PubMed ID: 4540626
[No Abstract] [Full Text] [Related]
12. Nonhomogeneous distribution of 5-hydroxyindoleacetic acid and homovanillic acid in the lumbar cerebrospinal fluid of man.
Jakupcević M; Lacković Z; Stefoski D; Bulat M
J Neurol Sci; 1977 Mar; 31(2):165-71. PubMed ID: 839230
[TBL] [Abstract][Full Text] [Related]
13. Reduced brain delivery of homovanillic acid to cerebrospinal fluid during human aging.
Rapoport SI; Schapiro MB; May C
Arch Neurol; 2004 Nov; 61(11):1721-4. PubMed ID: 15534183
[TBL] [Abstract][Full Text] [Related]
14. Monoamine acid metabolites and cerebrospinal fluid dynamics in normal pressure hydrocephalus: preliminary results.
Maira G; Bareggi SR; Di Rocco C; Calderini G; Morselli PL
J Neurol Neurosurg Psychiatry; 1975 Feb; 38(2):123-8. PubMed ID: 1151392
[TBL] [Abstract][Full Text] [Related]
15. Significance of decreased lumbar CSF levels of HVA and 5-HIAA in Alzheimer's disease.
Blennow K; Wallin A; Gottfries CG; Lekman A; Karlsson I; Skoog I; Svennerholm L
Neurobiol Aging; 1992; 13(1):107-13. PubMed ID: 1371850
[TBL] [Abstract][Full Text] [Related]
16. Cerebrospinal fluid homovanillic acid and parkinsonism in Huntington's disease.
Kurlan R; Goldblatt D; Zaczek R; Jeffries K; Irvine C; Coyle J; Shoulson I
Ann Neurol; 1988 Aug; 24(2):282-4. PubMed ID: 2972251
[TBL] [Abstract][Full Text] [Related]
17. Increased concentrations of the monoamine metabolites homovanillic acid and 5-hydroxyindoleacetic acid in lumbar and central CSF and of 3-methoxy-4-hydroxyphenylglycol in lumbar CSF after subarachnoid haemorrhage.
von Holst H; Lindquist C; Sedvall G
Acta Neurochir (Wien); 1985; 77(3-4):146-51. PubMed ID: 2416192
[TBL] [Abstract][Full Text] [Related]
18. CSF studies on the relationship between dopamine and 5-hydroxytryptamine in Parkinsonism and other movement disorders.
Davidson DL; Yates CM; Mawdsley C; Pullar IA; Wilson H
J Neurol Neurosurg Psychiatry; 1977 Dec; 40(12):1136-41. PubMed ID: 591981
[TBL] [Abstract][Full Text] [Related]
19. Increased CSF HVA response to arecoline challenge in Alzheimer's disease.
Pomara N; Stanley M; LeWitt PA; Galloway M; Singh R; Deptula D
J Neural Transm Gen Sect; 1992; 90(1):53-65. PubMed ID: 1281646
[TBL] [Abstract][Full Text] [Related]
20. Cerebrospinal fluid protein patterns in spasmodic torticollis.
Kjellin KG; Stibler H
Eur Neurol; 1975; 13(5):461-75. PubMed ID: 50948
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
